0000899243-20-029733.txt : 20201029
0000899243-20-029733.hdr.sgml : 20201029
20201029194521
ACCESSION NUMBER: 0000899243-20-029733
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201027
FILED AS OF DATE: 20201029
DATE AS OF CHANGE: 20201029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koppel Adam
CENTRAL INDEX KEY: 0001578965
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 201274248
MAIL ADDRESS:
STREET 1: C/O BROOKSIDE CAPITAL, LLC
STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON ST
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-27
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001578965
Koppel Adam
C/O BAIN CAPITAL LIFE SCIENCES INVESTORS
200 CLARENDON STREET
BOSTON
MA
02116
1
0
0
0
Common Stock
338120
I
See footnotes
Represents shares of Common Stock held by BC Perception Holdings, LP ("BC Perception").
Adam Koppel is a Managing Director of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, LP. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
/s/ Adam Koppel
2020-10-29